Back A A A Font Size Receive E-mail Alerts Press Releases

MicroPort® Panoramic Endoscope Design Wins iF DESIGN AWARD 2019


Shanghai, China – The winners of the iF DESIGN AWARD 2019 were recently selected out of 6,375 entries from more than 50 different countries. The Panoramic Endoscope Design submitted by Shanghai MicroPort Medical (Group) Co, Ltd. ("MicroPort®") was awarded the iF DESIGN AWARD 2019 with the unanimous approval of the jury panel.
The iF DESIGN AWARD was introduced in 1953 and is annually organized by the Hannover-based iF International Forum Design GmbH, which is the oldest design organization in Germany. The iF DESIGN AWARD is one of the most important design awards in the world and famous for its award rationale of Independent, Rigorous, and Reliable. It is intended to increase public awareness about design and commend the organizations that demonstrate creativity and innovation with regard to product development and design rationale.
The Panoramic Endoscope Design of MicroPort® improves the operation and viewing experience of the existing endoscopes in the digestive and urinary systems for the doctors. It substantially increases the convenience for the doctors to observe the different angles and positions of the organs inside the human body. Also, it provides more comprehensive angles to take pictures, facilitating more intuitive comparisons of the lesions for the doctors. The design won the unanimous approval from 67 international iF judges to be awarded the iF DESIGN AWARD. The honor was conferred after MicroPort® had submitted entries for the award for the very first time.
Only when the five elements - science and technology, craftsman spirit, artistic taste, free thought, and care and concern for humanity - undergo long, complex, messy and even painful collisions, and finally integrate together in a perfect fashion, can a wonderful medical product be created. MicroPort® integrates the pursuit of details and the perseverance in innovation into its corporate gene, in addition to the emphasis on people. MicroPort® not only pays attention to the development and design of specific products, but also has insights into the industry development trend and users' unmet needs constantly. The Panoramic Endoscope takes the approach of innovation in the design rationale to guide companies in the industry to closely follow the doctors' urgent needs. In the future, MicroPort® will continue to adhere to the Five Elements for Products, e.g. science and technology lay the foundation, the craftsman's spirit reflects a dedicated attitude, aspiring to have an artistic taste, free thought is the soul behind development and exploration, and care and concern for humanity is both the starting point and ending point, with respect to product development and innovation. MicroPort® will also follow the management credo of Eyes for Greatness, Hands on Details to commercialize the best and affordable therapeutic solutions to save and reshape or improve patients' lives.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 8 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to bringing about a people-centric SuperCluster of emerging medical technologies to provide the best yet accessible ways & means to prolong and reshape lives.

For more information, please refer to:

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 1998-2019 MicroPort Scientific Corporation

Leanne Li
Board Secretary and Vice President of Corporate General Affairs
MicroPort Scientific Corporation
Tel: (86)(21) 38954600-6957


[Prev]:MicroPort® Won 2018 Shanghai Municipality Gold Quality Prize
[Next]:MicroPort® Orthopedics Aspiration Medial Stability Total Knee Replacement System – PS Type Implant Obtains Approval in China